January 12, 2010 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Celgene Corporation, a stock transaction, valued at $1,294.17. The trade took place on January 12, 2010 and was disclosed on May 12, 2011 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.